×
Nihon Kohden EBITDA 2015-2024 | NHNKY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Nihon Kohden ebitda from 2015 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Nihon Kohden EBITDA 2015-2024 | NHNKY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Nihon Kohden ebitda from 2015 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$180.2B
Intuitive Surgical (ISRG)
$179.4B
Edwards Lifesciences (EW)
$47.6B
IDEXX Laboratories (IDXX)
$46B
Alcon (ALC)
$44B
DexCom (DXCM)
$34.9B
IQVIA Holdings (IQV)
$32.6B
Mettler-Toledo (MTD)
$26.3B
STERIS (STE)
$22.6B
Waters (WAT)
$17.8B
SONOVA HOLDING (SONVY)
$16.4B
Hologic (HOLX)
$14.5B
Sysmex ADR (SSMXY)
$10.4B
Penumbra (PEN)
$9.8B
Masimo (MASI)
$8.5B
Globus Medical (GMED)
$7.2B
Glaukos (GKOS)
$5.4B
Teleflex (TFX)
$5B
Integer Holdings (ITGR)
$3.8B
TransMedics (TMDX)
$3.6B
PROCEPT BioRobotics (PRCT)
$2.8B
LivaNova (LIVN)
$2.4B
Elekta AB (EKTAY)
$1.9B
Veracyte (VCYT)
$1.9B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B
Tandem Diabetes Care (TNDM)
$1.1B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B
Pulse Biosciences (PLSE)
$991M